Trial Profile
Catheter ablation of atrial fibrillation combined with dronedarone as a new hybrid therapy option
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2012
Price :
$35
*
At a glance
- Drugs Dronedarone (Primary) ; Amiodarone; Antiarrhythmics; Flecainide
- Indications Atrial fibrillation; Paroxysmal atrial fibrillation
- Focus Therapeutic Use
- 07 Sep 2012 New trial record
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.